Mresvia
Payments companies reported to CMS as associated with Mresvia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mresvia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mresvia
These are the largest totals companies reported as associated with Mresvia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gregory Poland | Rochester, MN | Internal Medicine | $14,204.43 |
| Todd Wolynn | Pittsburgh, PA | Pediatrics | $5,823.13 |
| Amesh Adalja | Pittsburgh, PA | Infectious Disease | $5,591.46 |
| Resa Bradeen | Happy Valley, OR | Pediatrics | $4,212.76 |
| Oluwatosin Goje | Cleveland, OH | Obstetrics & Gynecology | $4,000.00 |
| Amy Behrman | Philadelphia, PA | Internal Medicine | $3,156.25 |
| Steven Crawford | Oklahoma City, OK | Family Medicine | $3,147.49 |
| Hector Lopez Frisbie | Golden, CO | Physician Assistant | $3,093.75 |
| Meera Varman | Boise, ID | Pediatric Infectious Diseases | $2,886.80 |
| Aileen Marty | Miami, FL | Anatomic Pathology & Clinical Pathology | $2,875.00 |
Prescribed Mresvia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.